Engineered, high-affinity ACE2 receptors neutralize SARS-CoV-2
Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2 | Journal of Virology
Advances in developing ACE2 derivatives against SARS-CoV-2 - The Lancet Microbe
COVID-19 susceptibility: potential of ACE2 polymorphisms | Egyptian Journal of Medical Human Genetics | Full Text
Cells | Free Full-Text | SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling
Cells | Free Full-Text | Mechanistic Origin of Different Binding Affinities of SARS-CoV and SARS-CoV-2 Spike RBDs to Human ACE2
The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins | PLOS Biology
Predicting mammalian species at risk of being infected by SARS-CoV-2 from an ACE2 perspective | Scientific Reports
Receptors for SARS-CoV-2 Present in Wide Variety of Human Cells | The Scientist Magazine®
Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2 | Science
Pharmaceuticals | Free Full-Text | Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Frontiers | Analysis of ACE2 Gene-Encoded Proteins Across Mammalian Species
Frontiers | Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2
Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2 | PNAS
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor - ScienceDirect
The role of angiotensin-converting enzyme 2 (ACE2) genetic variations in COVID-19 infection: a literature review | Egyptian Journal of Medical Human Genetics | Full Text
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor | Nature
Designed Variants of ACE2-Fc that Decouple Anti-SARS-CoV-2 Activities from Unwanted Cardiovascular Effects | bioRxiv
SARS-CoV-2 receptor |Human ACE2-Fc | InvivoGen
SARS‐CoV‐2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells | The EMBO Journal
Sequence difference of angiotensin-converting enzyme 2 between nonhuman primates affects its binding-affinity with SARS-CoV-2 S receptor binding domain | Biosafety and Health
ACE2 expressing cells | A549 | InvivoGen
Expanded ACE2 dependencies of diverse SARS-like coronavirus receptor binding domains | PLOS Biology
Human recombinant soluble ACE2 in severe COVID-19 - The Lancet Respiratory Medicine
Frontiers | Regulated Intramembrane Proteolysis of ACE2: A Potential Mechanism Contributing to COVID-19 Pathogenesis?
